Overview

US Cycle Control and Blood Pressure Study

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Birth Control Patch Study
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Contraceptive Agents
Contraceptives, Oral
Ethinyl Estradiol
Gestodene